I think this is a great move. Good credentials to add to a good management team already. This company is definitely getting things right with respect to clinical development and being in a strong financial position sets them apart from a lot of the small cap ASX crowd. I'm a happy holder at the moment but if they dip closer to $0.30 I might add a little. GLTA
- Forums
- ASX - By Stock
- BNO
- Ann: Bionomics Recruits International Executive as CFO